Tarsus Pharma Stock Up 20% as Insider Sells $839K in RSU-Linked Trade

Tarsus Pharmaceuticals operates at the intersection of biotechnology and ophthalmology, focusing on unmet medical needs in eye care and related fields. The company's strategy centers on advancing first-in-class therapeutics through late-stage clinical development and commercialization. Its competitive edge lies in a differentiated pipeline addressing high-prevalence conditions with limited treatment options, supported by a specialized commercial infrastructure.Tarsus targets ophthalmologists, dermatologists ...